Persistent Symmetrical Drug-related Intertriginous and Flexural Exanthema (SDRIFE) Caused by Metoprolol: Resolution via Beta-blocker Switch
DOI:
https://doi.org/10.2340/actadv.v106.adv-2026-0743Keywords:
SDRIFE, Metoprolol, Allergy, Immunodermatology and Allergology, Dermatology & AllergologyDownloads
References
Andersen KE, Hjorth N, Menné T. The baboon syndrome: systemically‐induced allergic contact dermatitis. Contact Derm 1984; 10: 97–100. DOI: https://doi.org/10.1111/j.1600-0536.1984.tb00343.x
Häusermann P, Harr T, Bircher AJ. Baboon syndrome: systemic drug-related intertriginous and flexural exanthema. J Am Acad Dermatol 2004; 51: 22–26. DOI: https://doi.org/10.1111/j.0105-1873.2004.00445.x
Häusermann P, Bircher AJ. Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE). Br J Dermatol 2003; 149: 211–217.
Miyahara A, Kawashima H, Okubo Y, Hoshika A. A new proposal for a clinical-oriented subclassification of baboon syndrome and a review of baboon syndrome. Asian Pac J Allergy Immunol 2011; 29: 150–160.
Harbaoui S, Syed HA. Symmetrical drug-related intertriginous and flexural exanthema. In: StatPearls. 2025.
Chaudet KM, Russell-Goldman E, Horn TD, Schuler AM, Chan MP, Nazarian RM. Characterization of T-helper immune phenotype in symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) endorses a delayed-type hypersensitivity reaction. Am J Dermatopathol 2024; 46: 71–78. DOI: https://doi.org/10.1097/DAD.0000000000002455
Thyssen JP, Maibach HI. Drug‐elicited systemic allergic (contact) dermatitis – update and possible pathomechanisms. Contact Derm 2008; 59: 195–202. DOI: https://doi.org/10.1111/j.1600-0536.2008.01367.x
Muresan AM, Metze D, Böer-Auer A, Braun SA. Histopathological spectrum and immunophenotypic characterization of symmetrical drug-related intertriginous and flexural exanthema. Am J Dermatopathol 2021; 43: 103–111. DOI: https://doi.org/10.1097/DAD.0000000000001722
Magnolo N, Metze D, Ständer S. Pustulobullous variant of SDRIFE (symmetrical drug-related intertriginous and flexural exanthema). J Dtsch Dermatol Ges 2017; 15: 657–659. DOI: https://doi.org/10.1111/ddg.13031
Schuler AM, Smith EH, Chaudet KM, Bresler SC, Gudjonsson JE, Kroshinsky D, et al. Symmetric drug-related intertriginous and flexural exanthema: clinicopathologic study of 19 cases and review of literature. J Cutan Pathol 2021; 48: 1471–1479. DOI: https://doi.org/10.1111/cup.14090
Carrasco-Gómez L, Lecumberri A, Renilla-Arroyo JM, de la Hoz-Caballer B, Díaz-Montalvo L, Martínez-Botas J, et al. Diagnostic characterization of symmetrical drug-related intertriginous and flexural exanthema (SDRIFE): a retrospective study from a tertiary care hospital. Dermatol Ther 2025; 2025. DOI: https://doi.org/10.1155/dth/1433440
Tatu AL, Elisei AM, Chioncel V, Miulescu M, Nwabudike LC. Immunologic adverse reactions of β-blockers and the skin. Exp Ther Med 2019; 18: 955–959. DOI: https://doi.org/10.3892/etm.2019.7504
Morris J, Awosika AO, Dunham A. Metoprolol. In: StatPearls. 2025.
Bazroon AA, Alrashidi NF. Bisoprolol. In: StatPearls. 2025.
Ranugha PSS, Betkerur JB. Antihypertensives in dermatology Part II - Cutaneous adverse reactions to antihypertensives. Indian J Dermatol Venereol Leprol 2018; 84: 137–147. DOI: https://doi.org/10.4103/ijdvl.IJDVL_992_16
Published
How to Cite
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
